# FDA Inspection 1121341 - Seattle Reproductive Medicine, Inc., P.S. - February 28, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/seattle-reproductive-medicine-inc-ps/ee6e5e84-45a5-4ea0-8442-7c60c79e7acc
Source feed: FDA_Inspections

> FDA Inspection 1121341 for Seattle Reproductive Medicine, Inc., P.S. on February 28, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121341
- Company Name: Seattle Reproductive Medicine, Inc., P.S.
- Inspection Date: 2020-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1275096 - 2025-07-02](https://www.globalkeysolutions.net/records/fda_inspections/seattle-reproductive-medicine-inc-ps/8390ee68-05ae-4a8a-b774-77ba353298af)
- [FDA Inspection 1275096 - 2025-07-02](https://www.globalkeysolutions.net/records/fda_inspections/seattle-reproductive-medicine-inc-ps/b7d5f87e-8a87-4921-8b9b-d961c70b8138)
- [FDA Inspection 1121341 - 2020-02-28](https://www.globalkeysolutions.net/records/fda_inspections/seattle-reproductive-medicine-inc-ps/1d9328ab-133d-4b70-804c-69a994cee57d)
- [FDA Inspection 1121341 - 2020-02-28](https://www.globalkeysolutions.net/records/fda_inspections/seattle-reproductive-medicine-inc-ps/633b5f0b-0061-4893-be7a-5b58aa767d3f)
- [FDA Inspection 1019977 - 2017-07-11](https://www.globalkeysolutions.net/records/fda_inspections/seattle-reproductive-medicine-inc-ps/5bc6b48c-13b3-4366-bfbe-35597aff73d7)

Company: https://www.globalkeysolutions.net/companies/seattle-reproductive-medicine-inc-ps/26f70cff-dd9c-4142-8c98-9ca9f2e83f56

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d